Assuming that estrogen receptor-α signaling stimulates glioblastoma cell growth just as it does in other estrogen-sensitive cancer, we questioned to which extent the intrinsic capability of Ang II to transactivate estrogen receptor-α may influence its stimulatory effects on GBM cell growth. The gene discussed is AGT; the disease is cancer.